Abstract:The current clinical applications of bone morphogenetic proteins (BMPs) are limited to only a few specific indications. Locally controlled delivery of combinations of growth factors can be a promising strategy to improve BMP-based bone repair. However, the success of this approach requires the development of an effective release system and the correct choice of growth factors capable of enhancing BMP activity. Basic fibroblast growth factor (bFGF, also known as FGF-2) has shown promise in promoting bone repair, although conflicting results have been reported. Considering the complex biological activities of FGF-2, we hypothesized that FGF-2 can promote BMP-induced bone regeneration only if the dosage and kinetic parameters of the two factors are individually tailored. In this study, we conducted systematic in vitro studies on cell proliferation, differentiation, and mineralization in response to factor dose, delivery mode (sequential or simultaneous), and release rate. Subsequently, we designed individually controlled BMP-7 and FGF-2 release poly(lactide-co-glycolide) (PLGA) nanospheres attached to the poly( l -lactic acid) (PLLA) nanofibrous scaffolds. The data showed that BMP-7-induced bone formation was accelerated by a relatively higher FGF-2 dose (100 ng/scaffold) delivered at a faster release rate, or by a relatively lower FGF-2 dose (10 ng/scaffold) at a slower release rate in an in vivo bone regeneration model. In contrast, a very high dose of FGF-2 (1000 ng/scaffold) inhibited bone regeneration under all conditions. In vitro and in vivo data suggest that FGF-2 improved BMP-7-induced bone regeneration by coordinating FGF-2 dosage and release kinetics to enhance stem cell migration, proliferation, and angiogenesis. Statement of Significance Bone morphogenetic proteins (BMPs) are the most potent growth/differentiation factors in bone development and regeneration. However, the clinical applications of BMPs have been limited to only a few specific indications due to the required supraphysiological dosages with the current BMP products and their side effects. Locally controlled delivery of BMPs and additional growth factors that can enhance their osteogenic potency are highly desired. However, different growth factors act with different mechanisms. Here we report a nanofibrous scaffold that mimics collagen in size and geometry and is immobilized with biodegradable nanospheres to achieve local and distinct release profiles of BMP7 and FGF2. Systematic studies demonstrated low dose BMP7 and FGF2 with different temporal release profiles can optimally enhance bone regeneration.

Nanoparticle-modified chitosan-agarose-gelatin scaffold for sustained release of SDF-1 and BMP-2.

Silk Fibroin/chitosan Scaffold with Tunable Properties and Low Inflammatory Response Assists the Differentiation of Bone Marrow Mesenchymal Stem Cells.

Chitosan/biphasic Calcium Phosphate Scaffolds Functionalized with BMP-2-encapsulated Nanoparticles and RGD for Bone Regeneration.

BMP-2 encapsulated polysaccharide nanoparticle modified biphasic calcium phosphate scaffolds for bone tissue regeneration.

Sequential and Sustained Release of SDF-1 and BMP-2 from Silk Fibroin-Nanohydroxyapatite Scaffold for the Enhancement of Bone Regeneration.

MBG Scaffolds Containing Chitosan Microspheres for Binary Delivery of IL-8 and BMP-2 for Bone Regeneration.

Controlled Release of BMP-2 from a Collagen-Mimetic Peptide-Modified Silk Fibroin-Nanohydroxyapatite Scaffold for Bone Regeneration.

Porous Nano-Ha/collagen/plla Scaffold Containing Chitosan Microspheres for Controlled Delivery of Synthetic Peptide Derived from BMP-2.

The Enhancement of Osteogenesis by Nano-Fibrous Scaffolds Incorporating Rhbmp-7 Nanospheres.

Sustained delivery of BMP-2 enhanced osteoblastic differentiation of BMSCs based on surface hydroxyapatite nanostructure in chitosan-HAp scaffold

PLA tissue-engineered scaffolds loaded with sustained-release active substance chitosan nanoparticles: Modeling BSA-bFGF as the active substance

Nanofibrous 3D Scaffolds Capable of Individually Controlled BMP and FGF Release for the Regulation of Bone Regeneration

Enhanced Osteogenesis of Bone Morphology Protein-2 in 2-N,6-o-sulfated Chitosan Immobilized PLGA Scaffolds.

2-N, 6-O-sulfated Chitosan-Assisted BMP-2 Immobilization of PCL Scaffolds for Enhanced Osteoinduction.

Self-assembled Biodegradable Nanoparticles and Polysaccharides As Biomimetic ECM Nanostructures for the Synergistic Effect of RGD and BMP-2 on Bone Formation

Zero-order controlled release of BMP2-derived peptide P24 from the chitosan scaffold by chemical grafting modification technique for promotion of osteogenesis in vitro and enhancement of bone repair in vivo

In Situ Controlled Release of Stromal Cell-Derived Factor-1Α and Antimir-138 for On-Demand Cranial Bone Regeneration.

Vascularization and Bone Regeneration in a Critical Sized Defect Using 2-N,6-o-sulfated Chitosan Nanoparticles Incorporating BMP-2.

Porous deproteinized bovine bone scaffold with three-dimensional localized drug delivery system using chitosan microspheres

Immobilization of nanocarriers within a porous chitosan scaffold for the sustained delivery of growth factors in bone tissue engineering applications

Stimuli-Responsive Codelivery System-Embedded Polymeric Nanofibers with Synergistic Effects of Growth Factors and Low-Intensity Pulsed Ultrasound to Enhance Osteogenesis Properties